Abstract:Right sided colorectal cancers (RCRCs) have distinct molecular phenotypes and clinical presentations to those on the left. Gut microbial co-metabolic interactions with the RCRC microenvironment are poorly defined and present a novel therapeutic target. Here, we present a multi-omics analysis of RCRCs. A prospective observational pilot study was performed at Imperial College London NHS Trust, UK. Treatment naive patients undergoing elective resectional surgery for primary RCRCs were recruited. Fresh intra-luminal fecal samples were obtained at three anatomical sites: 5 cm pre-, tumor, and 5 cm post-tumor. Microsatellite instability (MSI) and CDX2 expression were immunohistochemically evaluated. Metataxonomic analysis was carried out on a MiSeq Platform (Illumina, USA). Metabolomics analysis was performed using liquid chromatography mass spectrometry (Acquity UPLC, Xevo G2-S Q-TOF, Waters). After pre-processing, univariate and multivariate statistics were carried out in MetaboAnalyst and RStudio. 20 patients (8 females, mean age 69.9(53-83)) were included. Of the n=20 RCRCs, n=2 were ileo-cecal valve, n=4 were cecal, n=4 were cecum/proximal ascending colon, n=4 were mid-ascending colon, n=2 were ascending/hepatic flexure, n=2 were hepatic flexure, and n=2 were transverse colon cancers. Tumor classification according to TNM 8 indicated n=4 T1, n=1 T2, n=11 T3, n=4 T4; n=12 as N0, n=6 as N1, and n=2 as N2; n=2 as M0, n=1 as M1c, and n=17 as MX. All n=20 were CDX2 positive and n=16 had normal expression of mismatch repair proteins, n=4 showed MSI. Triglyceride (TG) species were significantly associated with T3-4 rather than T1-2 (p<0.01). Ceramide and diacylglycerol species were significantly associated with T1-2 rather than T3-4 (p<0.01). Multiple TG, an acyl carnitine, and a lysophosphatidic acid (LPA) species were associated with MSI status rather than no MSI status (p<0.01). An integrative analysis pipeline was developed to investigate statistically significant covariance between specific metabolites and taxa (p<0.01). Specifically, Procrustes similarity analysis of the multi-omics dataset revealed a negative correlation at pre- (p=0.606) and tumor level (p=0.738), but significant similarity at post-tumor level (p=0.045). This pattern in post-tumor may indicate cancer specific co-metabolism. At the post-tumor site, the LPA species increased in MSI, showed a negative correlation with members of the Oscillospiraceae family. Ceramide species, significantly increased in early-stage CRC, demonstrate negative correlation with the Lachnospiraceae family. Ongoing work is examining site-matched tissue samples utilizing imaging mass cytometry to define immune interactions. Mapping the intra-luminal fecal metabolome and metataxonome in RCRC reveals potential bacterial-host co-metabolic targets that could be leveraged for stratifying immunotherapy treatment. Citation Format: Petra Paizs, Duncan Roberts, Nathan Danckert, James Lewis, Maria Sani, Marta Jamroziak, Robert Goldin, Julian Marchesi, Lauren Ford, James Alexander, Zoltan Takats, James Kinross. Gut microbial co-metabolism influences the tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 3056.

Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling

Abstract 2887: Macrophage Conditioned Medium Promotes Colon Cancer Stem Cell Phenotype Via the Hedgehog Signaling Pathway

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

Macrophage Conditioned Medium Promotes Colorectal Cancer Stem Cell Phenotype Via the Hedgehog Signaling Pathway

Tumor-initiating Stem Cell Shapes Its Microenvironment into an Immunosuppressive Barrier and Pro-Tumorigenic Niche.

New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment

Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy

Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis

Abstract 5565: Multiomic characterization of colorectal cancer using MICS technology reveals interaction of antigen presenting cancer associated fibroblasts and T cells

Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer

Abstract 1393: Tumor-infiltrating monocyte-like cells create metastasis-promoting immunosuppressive microenvironment via THBS1 production in aggressive colorectal cancer

Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome

Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state

Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer

Crosstalk Between Mesenchymal Stem Cells And Macrophages In Inflammatory Bowel Disease And Associated Colorectal Cancer

Integrated multiomics analysis unveils how macrophages drive immune suppression in breast tumors and affect clinical outcomes

Tumor-induced Myeloid-Derived Suppressor Cells Promote Tumor Progression Through Oxidative Metabolism in Human Colorectal Cancer

Abstract 3056: Gut microbial co-metabolism influences the tumor microenvironment